BioWorld

Aug. 9, 2006

View Archived Issues

Inspire Terminating Phase II Trial Of INS50589 Antiplatelet

Inspire Pharmaceuticals Inc. may have hit the end of the road for a Phase II product designed for use in cardiopulmonary bypass procedures. (BioWorld Today) Read More

Neurocrine, Valentis Dropping Staff In Wake Of Drug Failures

Read More

After Knocking Out Genes, Rye Grass Pollen Made Sneeze-Free

Read More

Genizon Signs Genentech To Use Crohn's GeneMap

Read More

Other News To Note

Read More

Clinic Roundup

Read More